Moderna (MRNA) shares nearly tripled in Wednesday's session after it and Merck (MRK) announced positive trial results for its melanoma vaccine. Target (TGT) tapped 2-year highs and Estée Lauder (EL) surged after both companies posted strong earnings. Marley Kayden carries investors through the top stories of the trading session.